DIA Biosimilars 2013

Forest Laboratories

Positive phase III results with investigational antipsychotic Cariprazine

Friday, February 10, 2012 11:52 AM

Forest Laboratories and Gedeon Richter have released preliminary top-line results from a phase III clinical trial of cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with bipolar I disorder.

More... »

Cenduit: Now with Patient Reminders

Mersana Therapeutics appoints Michael A. Metzger as executive VP, COO

Wednesday, April 20, 2011 11:46 AM

Michael A. Metzger has joined Mersana Therapeutics, a platform-based cancer therapeutics company, as executive vice president & chief operating officer. 

More... »

CRF Health – eCOA Forum

U.S. government threatens to bar Forest CEO

Friday, April 15, 2011 12:27 PM

U.S. officials have sent a letter to Forest Laboratories chief executive Howard Solomon threatening him with a ban from participating in Medicare and Medicaid, according to Pharma Times.

More... »

Nycomed/Forest drug gains FDA approval

Tuesday, March 8, 2011 10:45 AM

The FDA has approved Nycomed and partner Forest Laboratories’ chronic obstructive pulmonary disease drug roflumilast, according to PharmaTimes.

More... »

Forest Laboratories to Acquire Clinical Data

Tuesday, March 1, 2011 08:40 AM

Buyout speculation fueled by the late-January approval of depression drug Viibryd (vilazodone) ended last week as Clinical Data of Newton, Mass., disclosed an offer much lower than analysts had expected, reported BioWorld Week.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs